Last reviewed · How we verify

NCT04123301

Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics.

Status unknown NA Last updated 10 October 2019
What this trial tests

NA trial testing Active Theta Burst Stimulation (TBS) in Depressive Episode in 90 participants. Status unknown.

Timeline
8 March 2019
Primary endpoint
1 March 2021
1 May 2021

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment90
Start date8 March 2019
Primary completion1 March 2021
Estimated completion1 May 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 65, any sex, with Depressive Episode or Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will perform a double-blind, randomized, sham-controlled clinical trial of theta-burst stimulation (TBS) in mixed depressive episodes of both bipolar and major depressive disorders. Will be selected 90 patients aged 18-65 years with diagnosis of TB (I or II) or MDD in moderate or severe major depressive episode with mixed features. The primary endpoint of efficacy will be a continuous outcome of change in Montgomery-Asberg Depression Rating Scale (MADRS) from baseline to week 3.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial.
    Tavares DF, Suen P, Rodrigues Dos Santos CG, Moreno DH, et al · · 2021 · cited 17× · PMID 34193961 · DOI 10.1038/s41386-021-01080-9
  2. Distractibility, anxiety, irritability, and agitation symptoms are associated with the severity of depressive and manic symptoms in mixed depression.
    Tavares DF, Suen P, Moreno DH, Vieta E, et al · · 2022 · cited 3× · PMID 36580584 · DOI 10.47626/1516-4446-2022-2606
  3. Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial.
    Tavares DF, Dos Santos CGR, Valiengo LDCL, Klein I, et al · · 2020 · cited 3× · PMID 32499730 · DOI 10.3389/fpsyt.2020.00435

Verify or expand the search:

Other recruiting trials for Depressive Episode

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04123301.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing